Hauptseite > Publikationsdatenbank > Novel 18F-labeled D4-receptor ligands > print

001     865229
005     20210130002950.0
024 7 _ |a 2128/23007
|2 Handle
037 _ _ |a FZJ-2019-04760
041 _ _ |a English
100 1 _ |a Willmann, Michael
|0 P:(DE-Juel1)173964
|b 0
|e Corresponding author
|u fzj
111 2 _ |a DPhG Annual Meeting 2019
|c Heidelberg
|d 2019-09-01 - 2019-09-03
|w Germany
245 _ _ |a Novel 18F-labeled D4-receptor ligands
260 _ _ |c 2019
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a CONFERENCE_POSTER
|2 ORCID
336 7 _ |a Output Types/Conference Poster
|2 DataCite
336 7 _ |a Poster
|b poster
|m poster
|0 PUB:(DE-HGF)24
|s 1569412294_25780
|2 PUB:(DE-HGF)
|x After Call
520 _ _ |a The role of the dopamine D4-receptor subtype in the development of neurodegenerative diseases such as schizophrenia has been discussed for several decades. Specific radiotracers for more detailed preclinical and clinical investigations are still missing so far. The objective of this study was to develop D4-selective radioligands for positron emission tomography (PET). The selected lead structures exhibit high D4R subtype selectivity and a suitable LogP values, rendering them attractive for the development of a D4-selective radioligand for PET-imaging. Two D4R-ligands, know from literature, were selected for labeling with fluorine-18 (t1/2=108 min), the most ideal positron emitting nuclide.D4R-radioligand [18F]I was synthesized from 2-[18F]fluorophenylpiperazine 2, obtained by an alcohol enhanced Cu(II)-mediated radiofluorination of the Boc-protected precursor 1 followed by deprotection of the radiolabeled intermediate with TFA. Subsequently, [18F]I was obtained by reductive amination with 3 in a total isolated radiochemical yield of 7 % within 2 h. Three independent auto radiographic studies with molar activities up to 90 GBq/µmol showed high content of non-specific binding that covers any possible specific binding. The chiral D4R-radioligand [18F]II was also obtained by alcohol enhanced Cu(II)-mediated radiofluorination of the boronic acid precursor 4 in a RCY of 66±5 % within 60 min after isolation by semi-preparative HPLC. Preliminary in vitro autoradiographic study indicates specific binding of [18F]II in areas with D4-expression, consistent with results published earlier.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
700 1 _ |a Ermert, Johannes
|0 P:(DE-Juel1)131818
|b 1
|u fzj
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 2
|u fzj
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/865229/files/Abstract%20DPhG%202019%20Heidelberg_Willmann.pdf
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/865229/files/Poster.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/865229/files/Abstract%20DPhG%202019%20Heidelberg_Willmann.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/865229/files/Poster.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:865229
|p openaire
|p open_access
|p VDB
|p driver
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)173964
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131818
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a poster
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21